Skip to content
Inicio
Login
Descubre más: busca en todos nuestros recursos
All Fields
Title
Author
Subject
Find
Advanced
🎤
JAK2 is a critical therapeutic...
Text this
Text this:
JAK2 is a critical therapeutic target in VEXAS syndrome treated with ruxolitinib.
Number:
Provider:
Select your carrier
Cricket
T Mobile
Verizon
Virgin Mobile